ITGAM and neoplasm: We found that inhibiting CSF1R or VEGFR significantly reduced the number of CD11b+F4/80+ TAMs and particularly the number and percentage of M2 TAMs (F4/80+CD206+CD86−) (Fig. 4C, D) generated from co-culture with TAb2 tumor cells.